If you use various conventional treatment methods including steroids and deal with plaque psoriasis, you will be interested to know that the FDA very recently approved the Sernova topical steroid spray for the treatment of plaque psoriasis.
Dr. Reddy’s Laboratories announced in a press release, the approval of this the Sernova topical steroid spray which is designed for treatment in those 18 years of age and older who are dealing with mild to moderate plaque psoriasis. The spray was created by Promius Pharma which is a subsidiary of Dr. Reddy’s.
“The FDA approval of Sernivo Spray is a significant milestone for Promius, as it validates our committed efforts and resources to developing differentiated dermatology products from concept to commercial launch,” said G V Prasad, co-chairman and CEO of Dr. Reddy’s Laboratories, in a press release. “We are delighted to receive a first round FDA approval of Sernivo Spray as we look to expand our portfolio of medical dermatology products available in the US market.”
The FDA approval is based on data from 2 clinical trials involving patients who were randomly assigned to receive Sernivo Spray or a vehicle spray to affected areas twice daily for 28 days. Patients who used the intervention treatment saw significantly more success in treatment compared with the placebo group.
It is anticipated that this Sernova topical steroid spray 0.05% will be launched as soon as the next quarter.
Topical steroids have proven beneficial for many psoriasis sufferers due to their effectiveness in helping to reduce inflammation which is at the root of psoriasis flare-ups. Some steroids may also be able to reduce the itch associated with the skin lesions as well as reducing the thickness of the lesions. Topical steroids unlike many other topical treatments for psoriasis also do not take a long time to work.
While effective, topical steroids do have various risk factors associated with them especially if highly potent steroid formulations are used or if the steroids are used for a long time. When treatment is stopped, the flare-ups will usually return.
This Sernivo Spray is designed to be used not longer than four weeks and should not be used on the face, scalp, axilla, or the groin. It does come with side effects which were noted in the press release;
Common adverse reactions of (at least 1%) after 28 days of treatment with Sernivo Spray or placebo included application site reactions, including pruritus, burning and/or stinging, pain and atrophy, according to the release.
While the Sernivo topical steroid spray may be effective for some, it is obviously not a long-term treatment option and once you stop, you will have to deal with psoriasis symptoms again which can be very frustrating. This is why you need to give the holistic approach a chance because it is designed to give long-term relief from psoriasis. Find out more about an effective natural regimen for psoriasis in the proven Psoriasis Free For Life guide.